RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie
Hand-out
Press Releases
RA Capital Management, LP  
December 11, 2024

RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie

Closing marks second significant acquisition from RA Capital's Raven incubator in 2024, and first acquisition of a company built by Raven from a technology platform in-licensed from a large pharmaceutical

avatar profile Olean Times Herald

Olean Times Herald


Local & Social